Eugenol in combination with lactic acid bacteria attenuates Listeria monocytogenes virulence in vitro and in invertebrate model Galleria mellonella
Listeriolysin O
Galleria mellonella
DOI:
10.1099/jmm.0.000251
Publication Date:
2016-03-22T22:12:22Z
AUTHORS (4)
ABSTRACT
Listeria monocytogenes is a human enteric pathogen that causes severe foodborne illness in high-risk populations. Crossing the intestinal barrier first critical step for infection. Therefore, reducing L. colonization and invasion of epithelium production virulence factors could potentially control listeriosis humans. This study investigated efficacy sub-inhibitory concentration (SIC) plant-derived antimicrobial eugenol, either alone, or combination with five lactic acid bacteria (LAB), namely Bifidobacterium bifidum (NRRL-B41410), Lactobacillus reuteri (B-14172), fermentum (B-1840), plantarum (B-4496) Lactococcus lactis subspecies (B-633) adhesion to epithelial cells (Caco-2). Additionally, effect aforementioned treatments on listeriolysin production, E-cadherin binding expression genes was investigated. Moreover, vivo eugenol-LAB invertebrate model Galleria mellonella studied. Eugenol LAB, alone combination, significantly reduced (P < 0.05). decreased haemolysin gene In addition, enhanced survival rates G. infected lethal doses The results highlight antilisterial eugenol justify further investigations mammalian model.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (78)
CITATIONS (23)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....